TheodoreGeh-LuLiouMD

PubMed

• 1 citations
  Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis.
  Nicole Mayer-Hamblett, Alex H Gifford, Margaret Kloster, Renee Russell, Andrew T Braun
  Annals of the American Thoracic Society. 2024-11-01
• Patent Foramen Ovale and Oxygenation in Patients with Cystic Fibrosis.
  Haley Belt, Evbu O Enakpene, Judy L Jensen, Alice P Moe, Holly Carveth
  Respiration; International Review of Thoracic Diseases. 2024-10-08
• 3 citations
  Predicting weight gain in patients with cystic fibrosis on triple combination modulator.
  Kelly L Stewart, Rhonda Szczesniak, Theodore G Liou
  Pediatric Pulmonology. 2024-06-01

Journal Articles

• Right-to-Left Ventricular End Diastolic Diameter Ratio in Severe Sepsis and Septic Shock  
  Theodore G Liou, Brent D Wilson, Nathan D Hatton, Partha Sardar, Promporn Suksaranjit, Meghan M Cirulis, ScienceDirect
• Genetic discovery, rigorous statistics, and pandemic influenza  
  Scholand MB, Liou TG, Chest, 1/1/2014
• Lung transplantation for chronic obstructive pulmonary disease  
  Liou TG, Raman SM, Cahill BC, Transplant Research and Risk Management, 7/3/2013
• Use of older donors for lung transplantation-you can't get there from here  
  Cahill BC, Raman SM, Selzman CH, Liou TG, J Heart Lung Transplant, 1/1/2013
• Toxicity effects of short term diesel exhaust particles exposure to human small airway epithelial cells (SAEC) and human lung carcinoma epithelial cells (A549)  
  Tang M, Li Q, Xiao L, Li Y, Jensen JL, Liou TG, Zhou A, Toxicology Letters, 1/1/2012
• Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis  
  Liou TG, Adler FR, Keogh RH, Li Y, Jensen JL, Walsh W, Packer K, Clark T, Carveth H, Chen J, Rogers SL, Lane C, Moore J, Sturrock A, Paine R, III, Cox DR, Hoidal JR, PloS ONE, 1/1/2012
• Ivacaftor in Subjects with Cystic Fibrosis who are Homozygous for the F508del-CFTR Mutation  
  Flume PA, Liou TG, Borowitz DS, Li H, Yen K, Ordoñez CL, Geller DE, the VX08-770-104 Study Group, Chest, 1/1/2012
• The Changing Picture of Pulmonary Arterial Hypertension (PAH) Patients in the United States: How the REVEAL Registry Differs From Historic and Non-US Contemporary Regi...  
  Frost AE, Badesch DB, Barst RJ, Benza RL, Elliott CG, Farber HW, Krichman A, Liou TG, Raskob GE, Wason P, Feldkircher K, Turner M, McGoon MD, Chest, 1/1/2011
• Insulin Therapy to Improve BMI in Cystic Fibrosis Related Diabetes Without Fasting Hyperglycemia: Results of the CFRDT Trial  
  Moran A, Pekow P, Grover P, Zorn M, Slovis B, Pilewski J, Tullis E, Liou TG, Allen H; the CFRDT Study Group, Diabetes Care, 1/1/2009
• Lung Volumes  
  Liou TG, Kanner RE, Clinical Reviews in Allergy and Immunology, 1/1/2009
• Spirometry  
  Liou TG, Kanner RE, Clinical Reviews in Allergy and Immunology, 1/1/2009
• Lung transplantation and survival in children with cystic fibrosis  
  Liou TG, Adler FR, Cox DR, Cahill BC, The New England Journal of Medicine, 1/1/2007
• Lung transplantation for cystic fibrosis  
  Liou TG, Woo MS, Cahill BC, Current Opinions in Pulmonary Medicine, 1/1/2006
• Epidemiology of cystic fibrosis-related diabetes mellitus: The ESCF experience  
  Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, Morgan WJ et al, J Pediatrics, 1/1/2005
• Response to editorial letter to AJRCCM  
  Liou TG, Adler, F.R., AJRCCM, 1/1/2005
• Use of Lung Transplantation Survival Models to Refine Patient Selection in Cystic Fibrosis  
  Liou TG, Adler FR, Huang D, Am J Resp Crit Care Med, 1/1/2005
• Increasing pneumococcal vaccination rates among adults with cystic fibrosis  
  Young DC, Bleyl K, Clark T, Oderda G, Liou TG, Am J Health-Syst Pharm, 1/1/2004
• Influenza Vaccination Coverage Level in the Cystic Fibrosis Population  
  Marshall B, Henshaw C, Evans D, Bleyl K, Alder S, Liou T, Pediatrics, 1/1/2002
• Research letter: Priorities for lung transplantation among patients with cystic fibrosis  
  Liou TG, Adler FR, Cahill BC, et al, JAMA, 1/1/2002
• Selection of CF patients for lung transplantation  
  Liou TG, Marshall BC, Current Opinions in Pulmonary Medicine, 1/1/2002
• In Reply: Priorities for lung transplantation among patients with cystic fibrosis  
  Liou TG, Adler FR, Cahill BC, Marshall BC, JAMA, 1/1/2002
• A 5 Year Survivorship Model of Cystic Fibrosis  
  Liou TG, Adler FR, FitzSimmons S, Cahill BC, Hibbs JR, Marshall BC, American J. Epidemiol., 1/1/2001
• Thick mucus hypothesis in cystic fibrosis  
  Marshall BC, Liou TG, Lancet, 1/1/2001
• Lenercept (p55-Tumor Necrosis Factor receptor Fusion Protein) in Severe Sepsis and Early Septic Shock A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase ...  
  Abraham E, Laterre PF, Barbino J et al, Critical Care Medicine, 1/1/2001
• Survival Effect of Lung Transplantation for Patients with Cystic Fibrosis  
  Liou TG, Adler FR, Cahill BC, FitzSimmons S, Huang D, Hibbs JR, Marshall BC, JAMA, 1/1/2001
• Join now to see all

Books/Book Chapters

• Bronchial Asthma: A Guide for Practical Understanding and Treatment 
  Chapter: How the Pulmonary Function Laboratory Contributes to the Management of the Patient with Asthma 
  Kanner RE, Liou TGEditors: Gershhwin, M.E., Albertson,T..Humana Press, New York, New YorkEdition 5th,2006
• Bronchial Asthma: Principles of Diagnosis and Treatment; A Guide for Primary Care Physicians 
  Chapter: The role of the pulmonary function laboratory in patients with bronchial asthma 
  Kanner RE, Liou TGEditors: Gershhwin,M.E., Albertson,T..Humana Press, New York, New YorkEdition 4th,2002
• Rehabilitation of the Patient with Respiratory Disease, 
  Chapter: Impairment and Disability Evaluation 
  Liou TG, Kanner REEditors: Altose, M., Cherniack, N..McGraw-Hill, New York, New York1998

Abstracts/Posters

• Pulmonary vascular resistance in systemic sclerosis patients with pulmonary hypertension
  Hatton N, Frech T, Sawitzke A, Liou T, Markewitz B, CHEST, Honolulu, HI, 1/1/2011
• A mathematical model of biofilm formation
  Herald MC, Adler FR, Liou TG, North American Cystic Fibrosis Conference, Baltimore, MD, 1/1/2010
• The correlation of high mobility group box-1 protein, a pro-inflammatory biomarker, with clinical outcomes in CF
  Liou TG, Adler FR, Li Y, Sturrock A, Jensen J, Chen J, Clark T, Carveth H, Hoidal JR, Pediatric Pulmonology, North American Cystic Fibrosis Conference, Minneapolis, MN, 1/1/2009
• Improving the use of beneficial therapies in adult cystic fibrosis patients
  Gallegos A, Young DC, Clark T, Kinsfather J, Scott P, Carveth H, Liou TG, North American Cystic Fibrosis Conference, Orlando, Florida, 1/1/2008
• REVEAL Registry: Treatment History and Treatment at Baseline
  McGoon M, Barst R, Liou T, Miller D, Feldkircher K, Chest, Chicago, IL, 1/1/2007
• REVEAL Registry: Medical History and Time to Diagnosis of Enrolled Patients
  Elliott CG, Farber H, Frost A, Liou TG, Turner M, Chest, Chicago, IL, 1/1/2007
• Quantitative relationships between markers of inflammation and clinical disease in cystic fibrosis
  Liou TG, Chen J, Adler FR, McNulty MC, Jensen J, Rogers SL, Carver H, Clark T, Li Y, Carveth H, Pediatric Pulmonology, 20th North American Cystic Fibrosis Conference, Denver, CO, 1/1/2006
• Improving performance in the detection and management of CFRD in the Mountain West CF Consortium
  Liou TG, Brayshaw S, Brown M, Chatfield B, Jensen J, McDonald, CM, Koenig J, Peet K, Radford P, Reineke L, Otsuka K, Wagener J, Young D, 20th North American Cystic Fibrosis Conference, Denver, CO, 1/1/2006
• A mathematical model of inflammation in the cystic fibrosis airway
  McNulty MC, Adler FR, Liou TG, 20th North American Cystic Fibrosis Conference, Denver, CO, 1/1/2006
• Identification of factors affecting susceptibility to depression and influencing quality of life in adult cystic fibrosis patients based on age-at-diagnosis
  Israelsen M, Christensen NK, Liou TG, 20th North American Cystic Fibrosis Conference, Denver, CO, 1/1/2006
• A mathematical model of chronic airway inflammation
  McNulty MC, Adler FR, Liou, TG, Pediatric Pulmonology, 19th North American Cystic Fibrosis Conference, Baltimore, MD, 1/1/2005
• A mathematical model of airway inflammation in cystic fibrosis
  McNulty MC, Adler FR, Liou TG, ATS International Conference, San Diego, CA, 1/1/2005
• Cystic fibrosis related diabetes education (CFRD-E) survey: A national perspective
  Young DC, Shane-McWhorter L, Bleyl K, Oderda G, Haddadin B, Jensen J, Carver H, Carveth H, Liou T, Pediatric Pulmonology, 19th North American Cystic Fibrosis Conference, Baltimore, MD, 1/1/2005
• Survival after lung transplantation for cystic fibrosis: Implications for patient selection
  Liou TG, Adler FR, Huang D, The 18th North American Cystic Fibrosis Conference, St. Louis, MO, 1/1/2004
• Cleaved and inactivated Antithrombin III in bronchoalveolar lavage (BAL) samples from acute respiratory distress (ARDS) and at-risk for ARDS Patients
  Bock SC, Elstad MR, Grissom CK, Liou TG, Harris ES, Richer LD, Bao D, Lu A, Zuo Y, ATS International Conference, San Francisco, CA, 1/1/2001
• CF-related diabetes mellitus: The ESCF experience
  Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, Morgan WJ et al, 14th Annual North American Cystic Fibrosis Conference, Baltimore, Maryland, 1/1/2001
• Survival in Cystic Fibrosis and Optimal Timing of Lung Transplantation
  Liou TG, Adler FR, Cahill BC, FitzSimmons S, Hibbs JR, Marshall BC, Journal of Heart and Lung Transplantation, 1/1/2000
• Influenza Vaccination Coverage Level in the Cystic Fibrosis Population
  Marshall B, Henshaw C, Evans D, Bleyl K, Alder S, Liou T, International Cystic Fibrosis Meetings, Montreal, 1/1/1998
• Activated human polymorphonuclear neutrophils (PMN) secrete a non contact based crosstalk mediator that activates resting PMN
  Liou TG, Peng W, Farrukh IS, Hoidal JR, Am. J. Respir. Crit. Care Med., International Meetings of the American Thoracic Society, 1/1/1997
• Lung transplantation fails to improve survival for children with cystic fibrosis
  Liou TG, Chest, Salt Lake City, UT, 1/24/2006
• Update on Lung Transplants in Cystic Fibrosis
  Liou TG, Mountain West CF Consortium Meeting, Denver, Colorado, 1/19/2008
• Management Strategies for Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis
  Liou TG, Chest, Salt Lake City, UT, 1/24/2006
• Quantitative Relationships between Markers of Inflammation and Clinical Disease in Cystic Fibrosis
  Liou TG, 20th North American CF Conference, Denver, Colorado, 1/2./2006
• Referral Decisions for CF Patients Requiring Lung Transplantation
  Liou TG, 20th North American CF Conference, Denver, Colorado, 1/4./2006
• Advances in Cystic Fibrosis Lung Transplantation
  Liou TG, 5th Annual Spring Meetings of the Italian Cystic Fibrosis Research Foundation, Verona, Italy, 1/11/2007
• Join now to see all

Other

• Pulmonary function testing, Part I 
  Liou TG, Kanner RE, RT Magazine
  1/1/2005
• Pulmonary function testing, Part II 
  Liou TG, Kanner RE, RT Magazine
  1/1/2005
• American College of Physicians, PIER Project Module: Cystic Fibrosis 
  Shah A, Liou TG
  www.acponline.org
  1/1/2003